[ Price : $8.95]
Abbott Laboratories and its spin-off AbbVie agree to pay $25 million to resolve allegations that they used kickbacks and off-label...[ Price : $8.95]
FDA inspects a Minnesota medical center and finds violations that subjected unwitting patients to dangerous and unethical human te...[ Price : $8.95]
FDA approves a Jazz Pharmaceuticals supplemental NDA to revise labeling for Xyrem (sodium oxybate) oral solution to include an ind...[ Price : $8.95]
FDA Review posts the Federal Register notices for the week ending 10/26/2018.[ Price : $8.95]
Federal Register notice: FDA reopens the comment period for a revised draft product-specific guidance on sucralfate that appeared ...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Biopharmaceutics Classification System-Based Biowaivers tha...[ Price : $8.95]
Shire files a submission seeking FDA approval for a new plasma manufacturing operation near Covington, GA to manufacture Flexbumin...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension-related purposes the regulatory review period for Eli Lillys Taltz (i...